Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma

NCT03283046 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Similar to another study.

Conditions

Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
Multiple Myeloma

Interventions

DRUG: Nivolumab
DRUG: Lenalidomide
DRUG: Dexamethasone
DRUG: Ipilimumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]